Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

May 23, 2016

Amsterdam/Bangui—Doctors Without Borders/Médecins Sans Frontières (MSF) today pays tribute to dedicated staff member Arsène Bassanganam, who was killed during an ambush against on an MSF convoy in Central African Republic (CAR).

May 19, 2016

AMSTERDAM/BANGUI, CENTRAL AFRICAN REPUBLIC—A staff member of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) was shot and killed yesterday during an ambush on two MSF vehicles in Central African Republic (CAR), the organization said today, condemning the attack in the strongest possible terms.

May 19, 2016

The O’Neill Report is the British Government’s response to tackling the emerging antibiotic resistance crisis. In order to overcome this global threat, all countries must play their part and take action to address the crisis, including funding research and development for new tools—new classes of antibiotics, but also diagnostics and vaccines—while ensuring sustainable and affordable access for those new tools. At the same time, steps need to be taken to conserve existing antibiotics for as long as possible.

May 16, 2016

US officials are expected to use this week’s APEC meeting to discuss extending the length of monopoly market protection for biologic medicines and vaccines.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

May 11, 2016

Worst trade deal ever for access to medicines would restrict price-lowering generic competition and promote a broken innovation system

May 10, 2016

Gilead Sciences has been seeking patents in India for the hepatitis C drug sofosbuvir. The patent applications have been challenged by groups of people living with hepatitis C and HIV through "pre-grant oppositions." The patent just granted by India’s patent office was initially rejected in January 2015, just before President Obama’s visit to India, which was seen as vexing the US. Gilead appealed the rejection and the patent has now been granted.

May 06, 2016

In response to a statement by the Kenyan government that it intends to close its camps sheltering hundreds of thousands of Somali refugees, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) issued the following statement from Liesbeth Aelbrecht, MSF head of mission in Kenya:

May 06, 2016

Sharonann Lynch, HIV policy advisor at Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, made the following statement on the release of the United Nations Secretary General report on HIV/AIDS ahead of the June UN High Level Meeting on HIV—“Implementation of the Declaration of Commitment on HIV/AIDS and the Political Declarations on HIV and AIDS: On the Fast-Track to End the AIDS epidemic.”

May 05, 2016

Last year, 75 hospitals managed or supported by international medical organization Doctors Without Borders/Médecins Sans Frontières (MSF) were bombed. This was in violation of the most fundamental rules of war, which give protected status to medical facilities and its patients, regardless of if the patients are civilians or wounded combatants.

Pages